Skip to main content
logo
Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,778.00
-2.00 (-0.11%)
At close: Aug 20, 2026

Prestige Biologics Ratios and Metrics

Millions KRW. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Dec '22 Dec '21
Market Capitalization
138,400283,797245,391272,542184,546453,181
Market Cap Growth
-52.41%15.65%-9.96%47.68%-59.28%-
Enterprise Value
222,828364,568378,645369,331283,846447,789
Last Close Price
1780.003650.003990.004460.003020.009600.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Dec '22 Dec '21
PS Ratio
7.6822.64113.13156.1111855.95140.44
PB Ratio
1.292.103.422.731.574.24
P/TBV Ratio
1.302.123.462.761.584.31

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Dec '22 Dec '21
EV/Sales Ratio
12.3629.09174.57211.5518235.34138.77

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Dec '22 Dec '21
Debt / Equity Ratio
0.790.682.411.601.010.73
Net Debt / Equity Ratio
0.780.672.001.150.880.39
Net Debt / EBITDA Ratio
-2.95-4.36-6.47-3.62-3.60-1.80
Net Debt / FCF Ratio
91.10-3.82-8.51-1.90-0.87-0.34
Asset Turnover
0.070.050.01-00.03
Inventory Turnover
1.421.280.89-0.000.14
Quick Ratio
0.020.060.340.530.541.59
Current Ratio
0.250.400.600.790.921.93
Return on Equity (ROE)
-29.36%-26.55%-34.26%--44.30%-74.70%
Return on Assets (ROA)
-10.04%-7.52%-7.02%--9.85%-13.05%
Return on Capital Employed (ROCE)
-33.20%-20.10%-17.00%-18.50%-16.20%-15.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Dec '22 Dec '21
Earnings Yield
-25.60%-9.68%-11.97%-14.47%-26.94%-8.69%
FCF Yield
0.67%-8.29%-6.87%-22.11%-64.36%-27.17%
Buyback Yield / Dilution
-41.09%-20.50%-4.32%-13.35%-16.43%-25.46%